Blog Browse - Two Blokes Trading

Posted Apr 4 by Two Blokes

Earnings Per Share (EPS) of $1.10, surpassing the Zacks Consensus Estimate by 26.44%. Revenue reached approxi

Posted Apr 4 by Two Blokes

Adverum Biotechnologies, Inc. (NASDAQ:ADVM) is under investigation by Pomerantz LLP for potential securities

Posted Apr 4 by Two Blokes

Guess?, Inc. (NYSE: GES) reported earnings per share of $1.48, beating estimates and showcasing strong market

Posted Apr 4 by Two Blokes

Lifecore Biomedical reported an EPS of -$0.47, missing the estimated EPS by a significant margin. The company

Posted Apr 4 by Two Blokes

Earnings per share of $0.963, beating the estimated $0.901. Revenue reached approximately $1.29 billion, surp

Posted Apr 4 by Two Blokes

Earnings Expectations: Analysts predict an EPS of $1.78 and revenue of approximately $898.5 million for Q2 fi

Posted Apr 4 by Two Blokes

Insight into APA Corporation's Recent Stock Purchase and Market Performance On April 3, 2025, Joung Chansoo

Posted Apr 3 by Two Blokes

NVIDIA (NASDAQ:NVDA) saw its rating lowered from Buy to Hold by HSBC analysts, who also reduced the price targ

Posted Apr 3 by Two Blokes

Raymond James reiterated its Outperform rating and $250 price target on Apple (NASDAQ:AAPL), but warned that l

Posted Apr 3 by Two Blokes

UBS is holding firm on its Buy rating for CME Group (NASDAQ:CME), maintaining a $290 price target as strong tr

Posted Apr 3 by Two Blokes

UBS has reaffirmed its Sell rating on Kohl’s (NYSE:KSS) and maintained a $5.00 price target, signaling continu

Posted Apr 3 by Two Blokes

Mizuho raised its rating on Eastman Chemical (NYSE:EMN) from Neutral to Outperform, assigning a new price targ